Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Northwestern University
Headquarters: Evanston, IL, United States of America
Website: http://www.northwestern.edu
Year Founded: 1850
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Nov 7, 2024
Discovery & Translation
Science Spotlight: Multi-epitope antivirals, metastatic transition, and more
BioCentury’s roundup of translational innovations also includes a study from Amgen and a newco spotlight
BioCentury | Aug 2, 2024
Distillery Therapeutics
Increasing hexosamine synthesis for α-synucleinopathies
BioCentury | Feb 10, 2024
Discovery & Translation
Science spotlight: Moonlight’s enhanced T cells; plus a HUNK inhibitor and more
BioCentury’s roundup of translational innovations
BioCentury | Dec 15, 2023
Discovery & Translation
New targets at ASH point to AML combos, continued sickle cell interest
Innovation in protein degradation also on display, while immunotherapy targets are notably absent
BioCentury | Oct 25, 2023
Finance
Oct. 25 Quick Takes: U.K. takes next step in pension fund reforms
Plus: CBC-backed R-Bridge realizes royalty exit, and updates from Akebia, DermBiont, GSK and Flashpoint
BioCentury | Oct 13, 2023
Discovery & Translation
eGenesis’ kidney xenotransplant; plus Epirium, Neurimmune and more
BioCentury’s roundup of translational innovations
BioCentury | Sep 14, 2023
Regulation
FDA to weigh how broadly to expand label for Alnylam’s Onpattro
FDA panel votes 9-3 that the benefits of Onpattro to treat ATTR cardiomyopathy outweigh risks
BioCentury | Sep 12, 2023
Discovery & Translation
Lurie winners show mitochondria is more than a powerhouse
Northwestern’s Navdeep Chandel and Harvard’s Vamsi Mootha share the FNIH’s 2023 prize for pioneering mitochondrial biology beyond ATP
BioCentury | Jul 7, 2023
Discovery & Translation
Smaller gene editors, Resilience’s cell-free antibody discovery platform and more
BioCentury’s roundup of translational innovations
Items per page:
1 - 10 of 274